Cannabinoid Use Tied to Adverse Outcomes With COPD
In older adults with COPD, cannabinoid use tied to all-cause mortality, hospitalizations
Polypharmacy Common in Seniors With Heart Failure
With increasing number of medications, more rapid increase seen in number of noncardiovascular meds
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
ACS: Tranexamic Acid No Better Than Placebo After Severe Injury
Antifibrinolytic agent may lower 30-day mortality when used within one hour of injury, for severe shock
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
Glecaprevir and Pibrentasvir Aid HCV D+/R− Kidney Transplants
Two studies demonstrate safe transplant of kidneys from deceased donors with HCV infection
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
FDA Warns Companies About Illegal Sales of Dietary Supplements
The supplements contain cesium chloride, but no cesium chloride-containing products are FDA-approved
One Size May Not Fit All for Postoperative Opioid Prescribing
Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some
More Than Half of Cancer Patients Willing to Enroll in Clinical Trials
Participation rates similar for Black and White patients, treatment and cancer control trials
